Organon & Co. Stock Prediction
AI-powered sentiment analysis and prediction trends for OGN, updated each market day.
OGN AI Sentiment
AI predicts Organon & Co. stock is likely to increase over the next 10 market days.
Prediction date: May 20, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Organon & Co.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Sector
Exchange
Market Cap
$3,508,347,516
Cap Tier
Employees
10,000
Headquarters
JERSEY CITY, NJ
Listed Since
May 14, 2021
Website
OGN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
OGN Volatility
Organon & Co. has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
